Risk Stratification and Treatment of Acute Promyelocytic Leukemia (APL)

Discussion on risk stratification and treatment of Acute Promyelocytic Leukemia (APL) including the use of Atra plus ATO as the cornerstone treatment and the categorization of APL into three risk categories.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app